Beijing Balance Medical Technology Co., Ltd. logo

Beijing Balance Medical Technology Co., Ltd. (688198)

Market Open
10 Aug, 06:57
SSE SSE
¥
81. 96
+0.56
+0.688%
¥
16.53B Market Cap
- P/E Ratio
3.2% Div Yield
914,074 Volume
- Eps
¥ 81.4
Previous Close
Add Transaction
Day Range
81.65 84.37
Year Range
75 132.94
Want to track 688198 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

688198 trading today higher at ¥81.96, an increase of 0.688% from yesterday's close, completing a monthly decrease of -8.9333% or -¥8.04. Over the past 12 months, 688198 stock lost -23.2153%.
688198 is not paying dividends to its shareholders.
The last earnings report, released on May 13, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Beijing Balance Medical Technology Co., Ltd. has completed 1 stock splits, with the recent split occurring on May 26, 2022.
The company's stock is traded on one exchange.

688198 Chart

People also search for

Zhangzhou Pientzehuang Pharmaceutical Co., Ltd.
¥ 140.8
+0.7369%
Shanghai United Imaging Healthcare Co., Ltd.
¥ 112.74
+0.0355%
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
¥ 30.71
+0.8207%
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. A Shares
¥ 140
+2.1898%
Beijing Tiantan Biological Products Co., Ltd.
¥ 12.85
+0.5477%

Beijing Balance Medical Technology Co., Ltd. (688198) FAQ

What is the stock price today?

The current price is ¥81.96.

On which exchange is it traded?

Beijing Balance Medical Technology Co., Ltd. is listed on SSE.

What is its stock symbol?

The ticker symbol is 688198.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 3.2%.

What is its market cap?

As of today, the market cap is 16.53B.

Has Beijing Balance Medical Technology Co., Ltd. ever had a stock split?

Beijing Balance Medical Technology Co., Ltd. had 1 splits and the recent split was on May 26, 2022.

Beijing Balance Medical Technology Co., Ltd. Profile

Health Care Equipment & Supplies Industry
Healthcare Sector
Dr. Lei Jin CEO
SSE Exchange
CNE100005X15 ISIN
CN Country
473 Employees
25 May 2023 Last Dividend
26 May 2022 Last Split
- IPO Date

Overview

Beijing Balance Medical Technology Co., Ltd., founded in 2005 and headquartered in Beijing, China, specializes in the field of animal-derived implantable medical devices. The company is dedicated to the research and development, production, sale, and service of these critical medical tools. They play a pivotal role in the healthcare sector by providing innovative solutions for heart valve replacement and repair, congenital heart disease implant intervention, and surgical soft tissue repair. These technologies are vital across various surgical departments, including cardiothoracic surgery, neurosurgery, general surgery, and more, highlighting the company's essential contribution to modern medical procedures.

Products and Services

  • Artificial Biological Heart Valves

    These include both bovine pericardial and porcine aortic valves, designed to replace or repair the patient's heart valve, ensuring the heart continues to pump blood effectively. Suitable for patients requiring heart valve replacement due to conditions like valve stenosis or regurgitation.

  • Pulmonary Valved Conduit

    A device used in heart surgeries to replace parts of the heart's pulmonary artery or its valves, allowing for better blood flow from the heart to the lungs. Ideal for treating congenital heart defects and other conditions affecting the pulmonary artery.

  • Tissue Antigen Removal Processor

    Technology designed to remove antigens from tissue used in transplant and repair procedures, reducing the likelihood of rejection and improving the compatibility of implantable devices with the patient's immune system.

  • Annuloplasty and Valvuloplasty Rings

    Devices used in the repair of heart valves, where the ring is implanted to reshape and stabilize the valve opening, ensuring it functions correctly. These are critical in procedures aimed at improving or restoring valve function without replacement.

  • Surgical Biological Patches

    Biological materials used to repair damaged soft tissues in various surgical applications, including cardiothoracic, neurosurgery, and general surgery. These patches promote healing and tissue regeneration, offering a versatile solution for complex surgical repairs.

  • Bovine Pericardial Valves

    Heart valves made from bovine pericardial tissue, offering an alternative to synthetic materials and human donor tissues. These are used in heart valve replacement surgeries, providing a durable and biocompatible option for patients.

  • Pulmonary Artery Valved Pipeline, Outflow Tract Single Flap Patches

    Specialized devices designed for interventions in the pulmonary artery and heart's outflow tract, assisting in the management and treatment of congenital heart defects and diseases affecting these critical areas.

Contact Information

Address: Science and Technology Park, Beijing, China, 102200
Phone: 86 10 6073 5920